Septerna, Inc. (SEPN) vs Xencor, Inc. (XNCR)
- Septerna, Inc. SEPN 36.05 −3.74%
- Xencor, Inc. XNCR 22.95 −4.38%
Septerna, Inc. and Xencor, Inc. are both Biotechnology companies. Septerna, Inc. and Xencor, Inc. are of similar size ($1.8B and $1.8B). Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against −28.6%. Septerna, Inc. has the higher net margin (−24.5% vs −155.6%) and the higher return on invested capital (−189.0% vs −288.7%). Across the 15 metrics below, Septerna, Inc. leads on 12 and Xencor, Inc. on 3.
Valuation
Profitability
| Metric | SEPN | XNCR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (44.04%) | (205.84%) | 0.00% |
| Net margin | (24.51%) | (155.59%) | 0.00% |
| Free cash flow margin | 118.93% | (198.42%) | 0.00% |
| Return on equity | (6.34%) | (29.07%) | (56.36%) |
| Return on assets | (4.94%) | (20.36%) | (48.04%) |
| Return on invested capital | (189.01%) | (288.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack